HB Wealth Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.55M Sell
28,155
-748
-3% -$62.7K 0.01% 413
2026
Q1
$2.31M Buy
28,903
+1,509
+6% +$124K 0.02% 399
2025
Q4
$2.34M Buy
27,394
+1,788
+7% +$147K 0.02% 382
2025
Q3
$1.99M Buy
25,606
+2,062
+9% +$161K 0.01% 410
2025
Q2
$1.84M Buy
23,544
+1,982
+9% +$148K 0.01% 401
2025
Q1
$1.56M Buy
21,562
+5,577
+35% +$399K 0.01% 434
2024
Q4
$1.18M Sell
15,985
-891
-5% -$62.4K 0.01% 384
2024
Q3
$1.11M Buy
16,876
+454
+3% +$33K 0.01% 370
2024
Q2
$1.52M Buy
16,422
+4,493
+38% +$398K 0.02% 299
2024
Q1
$1.14M Sell
11,929
-58
-0.5% -$4.87K 0.01% 331
2023
Q4
$914K Buy
11,987
+2,388
+25% +$166K 0.01% 332
2023
Q3
$665K Sell
9,599
-711
-7% -$57.1K 0.01% 370
2023
Q2
$973K Buy
10,310
+192
+2% +$16.7K 0.02% 294
2023
Q1
$837K Buy
10,118
+1,107
+12% +$87K 0.01% 312
2022
Q4
$672K Sell
9,011
-1,672
-16% -$129K 0.01% 338
2022
Q3
$883K Sell
10,683
-165
-2% -$15.9K 0.02% 274
2022
Q2
$1.03M Buy
10,848
+762
+8% +$78.9K 0.02% 249
2022
Q1
$1.19M Buy
10,086
+601
+6% +$67.4K 0.02% 249
2021
Q4
$1.23M Buy
+9,485
New +$1.11M 0.02% 215

Other funds holding EW

HB Wealth Management's EW Position: Q2 2026 in Review

HB Wealth Management reduced its Edwards Lifesciences (EW) stake by 2.6% in Q2 2026, selling an estimated $62.7K and leaving 28,155 shares worth $2.55M. The position accounts for 0.01% of the portfolio, ranked #413.

HB Wealth Management first reported a position in EW in Q4 2021 and has held it in 19 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • HB Wealth Management held 28,155 shares of Edwards Lifesciences worth $2.55M as of Q2 2026.
  • HB Wealth Management sold 748 Edwards Lifesciences shares in Q2 2026, an estimated $62.7K.
  • Edwards Lifesciences made up 0.01% of HB Wealth Management's portfolio in Q2 2026, its #413 holding.
  • HB Wealth Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.